299 related articles for article (PubMed ID: 1318197)
41. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A
Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955
[TBL] [Abstract][Full Text] [Related]
42. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1.
Mori S; Takeuchi T; Ishii Y; Kukimoto I
J Virol; 2020 May; 94(10):. PubMed ID: 32132238
[TBL] [Abstract][Full Text] [Related]
43. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
44. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang SM; McCance DJ
J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
[TBL] [Abstract][Full Text] [Related]
45. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
[TBL] [Abstract][Full Text] [Related]
46. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
47. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
48. Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics.
Lee KA; Kang JW; Shim JH; Kho CW; Park SG; Lee HG; Paik SG; Lim JS; Yoon DY
Gynecol Oncol; 2005 Oct; 99(1):142-52. PubMed ID: 16038965
[TBL] [Abstract][Full Text] [Related]
49. A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.
O'Connor MJ; Stünkel W; Zimmermann H; Koh CH; Bernard HU
J Virol; 1998 Dec; 72(12):10083-92. PubMed ID: 9811748
[TBL] [Abstract][Full Text] [Related]
50. Biologic activity of human papillomavirus type 16 E6/E7 cDNA clones isolated from SiHa cervical carcinoma cell line.
Yamada T; Yamashita T; Nishikawa T; Fujimoto S; Fujinaga K
Virus Genes; 1995; 10(1):15-25. PubMed ID: 7483285
[TBL] [Abstract][Full Text] [Related]
51. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1.
Xiao JH; Davidson I; Matthes H; Garnier JM; Chambon P
Cell; 1991 May; 65(4):551-68. PubMed ID: 1851669
[TBL] [Abstract][Full Text] [Related]
52. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
Mori S; Ishii Y; Takeuchi T; Kukimoto I
J Virol; 2023 Aug; 97(8):e0081523. PubMed ID: 37578237
[TBL] [Abstract][Full Text] [Related]
53. Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription.
Beger M; Butz K; Denk C; Williams T; Hurst HC; Hoppe-Seyler F
J Mol Med (Berl); 2001 Jun; 79(5-6):314-20. PubMed ID: 11485026
[TBL] [Abstract][Full Text] [Related]
54. Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1).
Takahashi H; Kobayashi H; Matsuo S; Iizuka H
Arch Dermatol Res; 1995; 287(8):740-6. PubMed ID: 8554386
[TBL] [Abstract][Full Text] [Related]
55. Identification of a new promoter in the early region of the human papillomavirus type 16 genome.
Braunstein TH; Madsen BS; Gavnholt B; Rosenstierne MW; Koefoed Johnsen C; Norrild B
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3241-3250. PubMed ID: 10567657
[TBL] [Abstract][Full Text] [Related]
56. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
58. Methylation sensitivity of the enhancer from the human papillomavirus type 16.
List HJ; Patzel V; Zeidler U; Schopen A; Rühl G; Stollwerk J; Klock G
J Biol Chem; 1994 Apr; 269(16):11902-11. PubMed ID: 8163489
[TBL] [Abstract][Full Text] [Related]
59. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
60. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
Bartsch D; Boye B; Baust C; zur Hausen H; Schwarz E
EMBO J; 1992 Jun; 11(6):2283-91. PubMed ID: 1318198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
